MedAvail Reaffirms FY23 Revenue $3M Vs $3M Est
Portfolio Pulse from Benzinga Newsdesk
MedAvail has reaffirmed its FY23 revenue forecast of $3M, which is in line with the estimates.

August 14, 2023 | 9:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
MedAvail's reaffirmation of its FY23 revenue forecast aligns with the current estimates, indicating no major changes in the company's financial outlook.
MedAvail's reaffirmation of its FY23 revenue forecast indicates that the company's financial outlook remains stable, with no major changes expected. This could potentially maintain investor confidence in the company, but it's unlikely to significantly move the stock price in the short term as the news is in line with current estimates.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100